Search

Happy New year - and UPDATED COVID-19 treatment guidelines!

With the New Year, new guidelines! Our COVID-19 therapeutic working group has revised our COVID-19 management guidelines. Of note, empiric antibiotics are strongly DISCOURAGED for mild and moderate disease. Investigational or off-label therapies should NOT be given outside of clinical trials (several ongoing clinical trials at the MUHC); Criteria are proposed for potential identification of hyperimmune response, with recommendations to consult ID for severe cases.



7 views0 comments

Recent Posts

See All

vancomycin dosing - new recommendations

Hi all, New guidelines have been posted, based on data showing lower risk of nephrotoxicity with AUC based dosing (rather than trough-based) for severe MRSA infections. Don’t hesitate to ask pharmacis

Welcome to the MUHC-ASP Blog!

We will use this function to update you on new developments or activities in therapeutic guidelines for the MUHC - stay tuned! Please feel free to click on Like (or Dislike!) as needed, and join our

+1 514-934-1934

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada